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Although not widely recognized clinically, evi-
dence of peripheral neuropathy in patients with
chronic venous insufficiency (CVI) has been reported
by several investigators.1-3 A commonly described
clinical characteristic of venous ulceration is less severe
pain and discomfort than expected. Minor trauma,
such as scratching from pruritus, is often responsible
for the initiation of venous ulceration. British investi-
gators demonstrated neurologic abnormalities on the
foot of limbs with CVI, an area not normally associ-
ated with skin breakdown in patients with venous
insufficiency.1,2 The supramalleolar area, which is
commonly prone to ulceration, was not assessed.
This study evaluated the cutaneous pressure
thresholds as determined with Semmes-Weinstein
filaments (Research Designs, Houston, Tex), and
then the findings were correlated with those of a
standard clinical neurologic examination. Pressure
aesthesiometry using Semmes-Weinstein filaments is
a convenient, simple, and inexpensive method used
for the detection of sensory loss in other diseases
characterized by ulceration and neuropathy.4-6
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Objective: Clinical and microscopic evidence suggests the existence of sensory neuropa-
thy in patients with severe chronic venous insufficiency (CVI). A clinical evaluation was
conducted to determine whether a sensory neuropathy was present and, if so, to deter-
mine its extent and distribution.
Methods: The study was performed in a university-affiliated Veterans Affairs Medical Center.
Twenty-three limbs were studied in 14 male veterans with mild or moderate CVI. The
exclusions included diabetes, previous ipsilateral extremity surgery, or other diseases associ-
ated with neuropathy. Sensory thresholds in the limbs with CEAP class 2 disease (n = 11)
were compared with the thresholds in the limbs with CEAP class 5 disease (n = 12) at nine
different sites on the foot, ankle, calf, thigh, and palm. Thenar and hypothenar thresholds
were measured as internal controls. Thresholds were determined by a pressure aesthesiome-
ter consisting of 20 graduated filaments that ranged from 1.65 to 6.65 (log10mg)(10) of
pressure. A complete, sensory motor assessment of the limb was performed by an experi-
enced neurosurgeon who specialized in peripheral nerve evaluation. The clinical variables
assessed were deep tendon reflexes, vibration, proprioception, and light touch. Venous
reflux was determined with duplex ultrasound scanning and air plethysmography.
Results: Sensory thresholds at the most common site of venous ulceration—just proxi-
mal to the medial malleolus—were significantly (P < .05) different between mild (class
2) and severe (class 5) CVI. Sensory abnormalities coincided with the extent of trophic
changes and did not reflect specific dermatomal or cutaneous nerve distributions. In
addition to light touch or pinprick, vibration sense and deep tendon reflexes were also
significantly worse in those with severe CVI.
Conclusion: Sensory neuropathy is a feature of severe CVI, and its distribution is coin-
cident with trophic changes. Because this is often unappreciated by the patient, it prob-
ably contributes to the propensity for deterioration from minor trauma.
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Accordingly, we evaluated and compared a group
of limbs with mild (CEAP class 2) and severe (CEAP
class 5) CVI. The patients were examined for clinical
evidence of neuropathy and severity of neuropathy,
if present. Sensory thresholds were determined at
nine sites on the upper and lower limbs. These sites
included both those areas usually associated with
venous insufficiency and those areas usually not
affected by venous insufficiency.
METHODS
The patients underwent evaluation for CVI with
clinical examination and were stratified according to
the CEAP clinical classification.7-9 Etiology, anatomy,
and pathophysiology were further characterized with
duplex ultrasound scanning and air plethysmography
(APG). Complete neurologic examinations were
conducted by an experienced, board-certified neuro-
surgeon with special expertise in peripheral nerve
evaluation. The neurologic examination included the
evaluation of deep tendon reflexes, motor strength,
and vibratory, light touch, and proprioceptive sensa-
tion. Cutaneous sensory thresholds were determined
with Semmes-Weinstein filaments at a total of nine
sites: seven on the lower limb and two on the ipsilat-
eral palmar surface (Fig 1). The sites were selected to
assess the anatomic areas most commonly affected by
the skin changes of CVI and to assess different der-
matomes and peripheral cutaneous nerve distribu-
tions. In the palm, thenar and hypothenar thresholds
were measured as internal controls.
Subjects were excluded if other conditions associat-
ed with known peripheral neuropathy precluded ade-
quate analysis (ie, diabetes mellitus, ethanol abuse, vit-
amin deficiencies). Likewise, limbs with prior surgery,
such as saphenectomy or open fracture reductions,
were excluded. Because limbs with open ulceration
(CEAP class 6) are difficult to evaluate objectively,
patients with this condition were excluded. The com-
parison was conducted between 12 patients with
CEAP class 5 disease (healed ulceration) and 11
patients with CEAP class 2 disease (varicose veins with-
out skin changes, edema, or ulceration).
Sensory thresholds were measured with a pressure
aesthesiometer consisting of 20 nylon filaments cali-
brated to buckle on application of a graduated longi-
tudinal force (F) ranging from 4.5 mg to 447g.
Pressure applied by Semmes-Weinstein filaments is
expressed as the log10(F in mg)(10). This logarithmic
scale expresses the threshold as a linear relationship
with corresponding values ranging from 1.65 to
6.65.10 For sensory examination, the patient was
blocked from visual observation during the applica-
tion of the test filament and was requested to verbal-
ize the sensation of touch and its specific location.
The testing was begun with an application of force
sufficient to dimple the skin, thereby “pinning” both
ends of the filament. The test filament was considered
sensed when the appropriate verbal response was
elicited at the bending of the “pinned” test filament
shaft. Initially, the largest and most rigid filament
(6.65) was applied to the palmar surface of the hand
to show the expected sensation before beginning the
actual threshold determinations. Beginning with the
largest filament, each site was evaluated in descending
order until the smallest filament was correctly identi-
fied by the subject. In equivocal situations, the
process was repeated with descending and ascending
strength filaments to arrive at a consistent result. Each
unidentified filament was presented three times
before it was recorded as not sensed. Both ascending
Fig 1. Numbered anatomic sites used for determination
of cutaneous sensory thresholds correspond with filament
data presented in Table I.
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and repetitive examinations were perfomed as an
internal cross check at the site. The examiner had to
carefully avoid the stimulation of the hair follicles or
the dragging of the tip of the filament on the skin
because inadvertent stimulation would falsely lower
the sensory threshold.11 The filament examinations
were performed independently by two examiners.
Neurologic examinations of the extremity were
performed by our neurosurgical collaborator. Specific
attention was directed to the evaluation of vibration
(with a 128-Hz tuning fork), light touch determined
with pin prick, patellar and achilles deep tendon
reflexes, proprioception or position sense, and motor
strength. The findings were assigned a score from 0 to
3 that respectively indicated absence of the finding,
diminished from normal, normal, or stronger than
normal. Finally, the filaments were applied to deter-
mine the sensory threshold of the extremity and to
localize and quantitate the changes in this threshold.
The non-invasive examination of the lower
extremity was conducted according to accepted
standards.12-15 A duplex scan survey evaluated the
deep venous system for evidence of prior thrombo-
sis or obstruction. Valves were considered to be
incompetent if reflux continued for more than 0.5
seconds. Perforator veins in the thigh or calf were
noted.12,14 APG was performed to evaluate the
severity of the venous insufficiency and was reported
as the venous filling index. Normal results were con-
sidered to be less than 2.0 mL/s.13,15
The data were analyzed and the groups were com-
pared with the Wilcoxon rank sum test. The neuro-
logic scores were analyzed with the exact text for trend
in ordered categories. Analyses were performed with
True Epistat (Epistat Services, Richardson, Tex) and
StatXact (Cytel Software Corp, Cambridge, Mass)
software, with statistical significance accepted when
the P value was less than .05. The project was evaluat-
ed and approved by the Institutional Review Board of
the Veterans Affairs New Jersey health care system.
RESULTS
The sensory thresholds at the most common site
of venous ulceration—just proximal to the medial
malleolus—were significantly different between limbs
with CEAP 2 (median, 3.61) and CEAP 5 (median,
4.65) disease (Table I). A significant difference also
was present at the following four sites: just proximal
to the lateral malleolus, the proximal medial and lat-
eral calf, and the thigh. The remainder of the tested
sites were not different between limbs with CEAP 2
and CEAP 5 CVI (Table I). Profoundly abnormal
examination results were recorded in three individu-
als with class 5 disease who were unable to appreciate
the presence of even the thickest, most rigid filament.
Objectively, sensory abnormalities coincided with
the extent of trophic changes and did not reflect spe-
cific dermatomal or cutaneous nerve distributions. A
representative skin biopsy taken from a limb with
severe CVI shows marked perineural degeneration,
edema, and collagen replacement (Fig 2).
Vibration, ankle and patellar deep tendon reflex-
es, and light touch and pinprick senses were dimin-
ished in limbs with CEAP 5 disease. Statistical analy-
sis results of the assigned values in the two groups
showed a significant difference in each of these cate-
gories (Table II). The motor evaluations and the pro-
prioceptive sense were not different between groups.
The least sensitive filament threshold was deter-
mined by each of two independent examiners for each
limb. A significant difference between the thresholds
was observed in the limbs with CEAP 2 CVI in com-
parison with the limbs with CEAP 5 CVI (Table III).
Rank correlation results between the examiners’
Table I. Sensory thresholds were measured at nine different anatomic sites innervated by different nerve
roots and cutaneous nerves (CEAP class 2 [mild CVI] and CEAP class 5 [severe CVI] limbs)
No. Site Dermatome Peripheral nerve trunk CEAP 2 (n = 11) P values* CEAP 5 (n = 12)
1 1st web space L5 vs S1 Deep peroneal N 3.22 (2.44 - 4.08) NS 4.08 (2.83 - 5.07)
2 Dorsal foot L5 Superficial peroneal N 3.22 (2.44 - 4.17) NS 4.24 (2.83 - 5.07)
3 Supramalleolar medial + 5 cm L4 Saphenous N 3.61 (2.44 - 4.17) .00001 4.65 (4.08 - 6.65)
4 Supramalleolar lateral + 5 cm S1 Sural N 3.84 (2.44 - 4.17) .0039 4.45 (3.84 - 6.45)
5 Proximal calf, medial +25 cm L4 Saphenous N 3.22 (2.36 - 4.08) .00021 4.24 (3.22 - 4.94)
6 Proximal calf, lateral + 25 cm L5 Lateral sural cutaneous N 3.22 (2.36 - 4.17) .007 4.17 (3.22 - 5.18)
7 Anterior thigh, knee + 10 cm L2,3 vs L3,4 Anterior femoral cutaneous N 2.83 (2.44 - 4.17) .007 3.96 (2.36 - 6.10)
8 Palm, thenar C7 Median N 3.22 (2.44 - 3.23) NS 3.03 (1.65 - 4.08)
9 Palm, hypothenar T1 Ulnar N 3.22 (2.44 - 3.84) NS 3.22 (1.65 - 4.17)
L, Lumbar; S, sacral; C, cervical; T, thoracic; N, nerve.
Values for sensory thresholds are expressed as log10(F in mg)(10); median (low value to high value).
*P values are derived from Wilcoxon rank sum test and specified if significant (if P > .05, NS).
sensory protection would translate into an increased
propensity for skin breakdown and ulcer formation.
As with diabetes or leprosy, diminished sensory per-
ception may contribute to skin breakdown in associ-
ation with other sources of injury (ie, pressure,
scratching). The prospective identification of limbs
at risk would provide a logical opportunity for the
follow-up evaluation of this potential risk factor for
ulcer recurrence. Although the appropriate level of
sensory impairment that would be associated with
such increased risk is undetermined at this time, the
ease and convenience of this examination lends itself
to screening at an initial examination for the plan-
ning of the treatment of CVI.
The techniques of filament application may have
an influence on the results. We used the methodol-
ogy as described by Levin et al.10 The thresholds in
the palm and the foot were similar in limbs with
CEAP 2 and CEAP 5 CVI. The normal sensory
thresholds for the lower limb above the malleolus
are not available from the literature. Holewski et al4
reported foot thresholds in healthy individuals, two
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assessments showed a strong agreement on the rela-
tive magnitude of the thresholds (Spearman rank cor-
relation: r = 0.75; P = .0002).
Although the limbs were assigned a CEAP class
on the basis of the clinical examination results, the
duplex scanning and APG examination results sug-
gested that the non-invasive abnormalities increased
with the increased clinical severity of CVI. The mean
number of incompetent valve segments differed sig-
nificantly between CEAP 2 and CEAP 5 CVI. Super-
ficial incompetence predominated in limbs with class
2 disease, and limbs with class 5 disease were remark-
able for combined superficial, deep, and perforating
vein incompetence. Post-thrombotic abnormalities
were recognized in six of the 12 limbs with class 5
disease. However, neither duplex scan nor outflow
fractions indicated a component of venous obstruc-
tion. Physiologically, the two groups were similar:
age, ankle brachial indices, and reflux (venous filling
index) were not significantly different between the
CEAP 2 and CEAP 5 groups (Table IV).
DISCUSSION
Measurement of sensory threshold testing con-
firmed the presence of sensory abnormalities in the
trophic areas of CVI skin. Localization to supra-
malleolar skin is an important addition to previous
observations. The magnitude of the sensory impair-
ment observed in the limbs with CEAP 5 disease
(5.31 and 5.07; Table III) was similar to that report-
ed as a significant sensory threshold in diabetes or
leprosy (5.07).4-6,16 In prospective studies, the
inability of the subject with diabetes to appreciate the
application of a 5.07 filament was a significant risk
factor and predicted subsequent ulceration of the
plantar surface skin of the foot.4,6 Because the neu-
ropathy is localized to the supramalleolar skin, the
individual with CVI is not prone to the development
of ulceration on the plantar or dorsal foot. Unlike the
subject with diabetes, the distribution of the neuro-
pathic abnormality is localized and does not manifest
a stocking or glove distribution. Whether the same
risk implications of impaired cutaneous sensation will
hold true for the limb of the patient with CVI will, of
course, require prospective evaluation.
Currently, it is not known whether the described
neuropathy contributes to injury. However, we do
know that a specific level of neuropathy will lead to
an increase in skin lesions in diseases that produce a
profound peripheral neuropathy (ie, leprosy, dia-
betes).4,5 Although the skin of the leg is not subject
to the same pressures as the plantar surface of the
foot, it is logical to hypothesize that the diminished
Fig 2. Electron photomicrograph of cutaneous nerve.
Note edema, fiber degeneration, and collagen replace-
ment (11,040· ).
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of which (his sites 8 and 9) correspond with our sites
1 and 2. Holewski and colleagues4 also reported a
dorsal web space threshold of 3.87 ± 0.07 and a dor-
sal foot threshold of 3.81 ± 0.07. These values were
similar to those values reported on the dorsal foot at
our sites 1 and 2 (Table I). The normal sensory
thresholds in the hand are expected to range from
2.44 to 2.83.11,17 The palmar sensory thresholds are
also similar to those thresholds reported at our sites
8 and 9 (Table I). Our thresholds in the palm may
be slightly higher because the tips of the fingers are
considered to be the most sensitive site in the hand.
Widely thought to be relatively pain free, cuta-
neous ulceration from venous insufficiency is often
managed in outpatient clinics. Point-specific pain
may represent exposed cutaneous nerve endings,
and diffuse pain is frequently associated with celluli-
tis, inflammation, and infection. Pain from exposed
nerve endings is only relieved with the restoration of
skin coverage, but the diffuse inflammatory compo-
nent often subsides with the commencement of effi-
cacious therapy—elevation, antibiotics, and com-
pression. Previous investigations have suggested the
presence of a neuropathic component to CVI.1,2
Morphologic study results from our institution have
identified the destruction of cutaneous nerve fibers
in areas subjected to chronic venous hypertension
(Fig 2).
Parkhouse and LeQuesne18 described the vaso-
dilatory flare response on the plantar surface of the
foot and used the technique to identify abnormalities
in the nociceptive C fibers, which are associated with
both sensation and the reflex response to wound
healing. The flare is an axon reflex vasodilation, the
intensity of which is diminished with local anesthesia
or peripheral neuropathy.18 Ardron et al2 evaluated
the dorsal surface of the foot in 15 limbs with severe
CVI with the vasodilatory flare. Shami et al1 com-
pared 40 patients with severe CVI (class 4 or higher)
with patients with healthy limbs. The threshold to
warming and to vibration (Ohio Bio-Thesiometer,
Newbury, Ohio) was significantly increased in the
CVI group. That group also identified abnormalities
of vibration and light touch.1 These investigators also
used the vasodilatory flare, and both reported their
observations on the foot. Taheri et al3 suggested the
presence of a diffuse neuropathy after electromyo-
graphic examinations and microscopic examinations
of four calf muscles and two sural nerves. Unlike the
Semmes-Weinstein filaments, these methods require
special equipment and are not conducive to wide-
spread screening examinations.
Like the results of these investigators, our obser-
vations suggest that the neurologic dysfunction
involves more than just cutaneous nerve fibers.
Although clinical expectations would implicate the
Table II. Neurologic examination scores (range, 0 to 3) in limbs with CEAP class 2 and class 5 disease
CEAP classification Examination score Vibration Light touch/pin prick Patellar DTR Achilles DTR
CEAP 2 (n = 9) 0 — — 1 (11%) 2 (22%)
1 — 3 (33%) — 1 (11%)
2 9 (100%) 6 (67%) 8 (89%) 6 (67%)
3 — — — —
Total 9 (100%) 9 (100%) 9 (100%) 9 (100%)
CEAP 5 (n = 11) 0 — — 7 (64%) 9 (82%)
1 8 (73%) 11 (100%) 1 (9%) 1 (9%)
2 3 (27%) — 3 (27%) 1 (9%)
3 — — — —
Total 11 (100%) 11 (100%) 11 (100%) 11 (100%)
P value* .0014 .0022 .0124 .0078
Motor strength and proprioceptive sense were not significantly different.
DTR, Deep tendon reflex.
*P values were derived from exact test for trend in ordered categories.
Table III. Least sensitive filament thresholds as
determined by different examiners in comparison
of limbs with CEAP 2 and CEAP 5 disease
Least sensitive filament Least sensitive filament
threshold: A threshold: B 
CEAP 2 4.08 (2.44 - 4.17) 4.08 (3.22 - 4.31)
CEAP 5 5.31 (4.17 - 6.65) 5.07 (4.31 - 6.65)
P value* <.0001 <.0001
Values for sensory thresholds are expressed as log10(F in mg)(10);
median (low value to high value).
*P values derived from Wilcoxon rank sum test and specified if
significant (if P > .05, NS).
Spearman rank correlation: r = 0.75; P = .0002, for correlation
between examiners.
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cutaneous sensory manifestations, a wider scope of
peripheral nerve dysfunction was observed encom-
passing joint innervation (deep tendon reflexes) and
sensory modalities. Thus, it is possible that venous
insufficiency also affects the subfascial peripheral
nerve trunks. Deep tendon reflexes are known to
diminish with age, which may account for the
decreased response observed in the group with class
2 disease.19 Because the mean ages of the two
groups were not different, the conclusions should
not be affected. Although the role of the neurolog-
ic specialist was objective reporting of the clinical
neurologic examination, the elimination of visual
clues that defined the two groups may have been
unavoidable. Although motor strength was intact to
clinical examination, we have previously reported an
association between a diminished ankle range of
motion, decreased calf pump function, and severe
CVI, which may also be related.13 Thus, in addition
to the demonstrated cutaneous sensory impairment,
we have also confirmed the diffuse peripheral nerve
dysfunction reported by other investigators.1-3
Several theories have been proposed to explain
the injury resulting from venous insufficiency. These
include the fibrin cuff and leukocyte trapping
hypotheses, both of which are thought to represent
an inflammatory response to chronic ambulatory
venous hypertension.20 Although the actual mecha-
nism of the neuropathy is unknown, it is not unlike-
ly that the same processes may be affecting the
peripheral nerve trunks in limbs with severe venous
insufficiency. Although it is clearly not the primary
risk factor, cutaneous sensory impairment in the
lower extremity may represent an important clinical
variable predisposing to recurrence of derrmal ulcer-
ation. The duplex scan and clinical examination
results objectively confirm the presence of venous
insufficiency in groups that do not differ significant-
ly in terms of age or arterial abnormality. The groups
both had substantial reflux, although deep vein
valvular abnormalities were more extensive in the
class 5 group. This study supports the concept of
localized neurologic injury at the site of maximal
cutaneous changes in limbs with venous hyperten-
sion, and this observation may prove important in
the future treatment and management of venous
ulceration.
We thank Dr Joan Skurnick for advice and assistance
with the statistical analysis and Dr David DeFouw for
assistance with preparation of the photomicrograph.
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Dr Gregory L. Moneta (Portland, Ore). Dr Padberg
and his colleagues are to be congratulated for bringing
before the American Venous Forum the concept of a mea-
surable peripheral neuropathy as a component of chronic
venous insufficiency. I believe that they have adequately
demonstrated that a neuropathy of some sort does exist in
these patients. I think it is important to keep in mind that
clearly the target organ in chronic venous insufficiency is the
skin. There is clearly an anatomic and functional microan-
giopathy of the cutaneous capillaries and lymphatics of the
perimalleolar region in patients with chronic venous insuffi-
ciency and lipodermatosclerosis. It is not surprising, indeed
I think it should be expected, that the cutaneous nerves of
lipodermatoslcerotic skin should, along with the capillaries
and lymphatics, also be affected by the cutaneous fibrosis
characterizing lipodermatosclerosis.
I have several questions for Dr Padberg. I wonder why
a control group without venous disease was not studied.
Without controls we really do not know whether the so-
called neuropathy of chronic venous insufficiency is a
chicken or an egg problem.
Secondly, did you control for edema? We all know that
patients with significant swelling in their feet and legs will
complain of altered sensation in the region of the swelling.
Patients with CEAP 2 disease by definition have no
edema, and patients with CEAP 5 disease may have severe
edema. How can we be sure that the decreased sensation
observed about the ankles in the patients with CEAP 5
disease is not merely a reflection of increased edema and
not really the result of a true neuropathy?
Also, I cannot understand conceptually why patients
with CEAP 5 chronic venous insufficiency should have
decreased deep tendon reflexes as compared with patients
with CEAP 2 disease. Is there a neurologic pathway that I
am unaware of that affects cutaneous nerves about the
ankle and the calf but not on the foot and also affects the
spinal reflex arc at the knee?
Finally, I enjoyed this paper very much. Its ultimate
value may be to lead to predicting which patients with
chronic venous insufficiency are at risk for the develop-
ment of an ulcer as a result of their inability to protect
themselves from minor trauma about the ankle. In this
respect, the testing described by Dr Padberg and col-
leagues in patients with chronic venous insufficiency may
be analogous as he has alluded to testing for altered sen-
sation in the feet of patients with diabetes. This may help
identify those who are at risk for venous ulceration.
I appreciate the opportunity to discuss this paper and
congratulate the authors on their fine work. Thank you.
Dr Frank T. Padberg, Jr. Thank you, Dr Moneta.
In answer to question one, why did we use no true
controls? The answer is that this is in process. In the pre-
sentation, I alluded to our desire to evaluate healthy limbs
and patients with CEAP 4 disease, and I think that would
give us the opportunity then to add a greater value to our
conclusions to where this may in fact represent a severity
of disease. With the recognition that hemodynamic signif-
icance was not shown in the final cohort of patients, I
agree that further study will be appropriate.
With regard to edema, I would say first of all that none
of these patients had edema at the time of their examina-
tions. Very few of them continued to have long-term
edema, but one of the other questions that would nor-
mally come up in this situation is the effect of the local scar
from the healing of an ulcer and whether that may have
had some impact as well. I think the fact that it is a more
global phenomenon instead of just the medial malleolar
site certainly implies that chronic venous insufficiency is
the cause. Secondly, oftentimes these patients will have
thickened skin and other abnormalities in the local area
that could give an abnormal reading with the filaments.
We tried not to evaluate patients who had thickening and
eschar present, and that is one of the reasons that we wait-
ed until they had stable healing and had reached a point
where that was no longer an issue.
Finally, I do not know of another nerve pathway or
spinal reflex arc. However, I do think that the fact that we
see changes in areas where there are not trophic changes
adds to the speculation that this is a more global phenom-
enon in the limb with chronic venous insufficiency than it
is to just the local area where we most commonly see the
secondary side effects.
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Dr J. Leonel Villavicencio (Washington, DC). I would
like to join Dr Moneta in congratulating you, Dr Padberg,
for your interesting study. I just wanted to share with you
observations that I have made in the course of the man-
agement of patients with congenital vascular malformations
of venous predominance. In operating on these patients, I
have noticed that the sural nerve, for example, is com-
pletely full of veins, congested. I have confirmed this obser-
vation in different areas of the leg and these individuals.
Sometimes these nerves are so large with tortuous varicose
veins and vena nervorum that I am sure that this is a cause
for problems with pain as well as changes in the sensation
of these individuals.
Thank you.
Dr Padberg. Thank you for sharing your immense
experience. The manuscript offers a reference to specific
microscopic evidence of neuropathic changes in the sural
nerves. I would also append a comment relating our find-
ings to those of diabetic microangiopathy, which probably
involves the neural sheath as well.
Dr Robert Kistner (Honolulu, Hawaii). I would cer-
tainly like to congratulate you on an important study and
a good contribution. Mine is a different question, and it is
about the use of the CEAP. I think that you are using
CEAP to point out the most serious level of involvement.
Had you used CEAP to catalogue all of the manifesta-
tions, we would now know how many patients had
swelling and induration in their legs. So the question is, do
you have that information? In other words, do you have
the varicose veins, the swelling, and the induration to go
along with the CEAP 5 group?
Dr Padberg. I have listed the specific valves that were
involved, if this is what you are referring to. Six of the limbs
were post-thrombotic. The limbs with class 5 chronic
venous insufficiency had a higher frequency of incompetent
valves. The information is summarized in the manuscript.
CORRECTION
In the Table of Contents of the October 1999 issue of the Journal of Vascular Surgery, an error in pro-
duction caused the first section of articles to be incorrectly labeled “Original Articles from the American
Venous Forum.” These articles should have been under the heading of “Original Clinical Science Studies.”
The papers from the American Venous Forum were not published in the October 1999 issue. We regret any
confusion that may have been caused by this error.
